Logo image of IEP.BR

IEP INVEST (IEP.BR) Stock Fundamental Analysis

EBR:IEP - Euronext Brussels - BE0003748622 - Common Stock - Currency: EUR

5.3  -0.05 (-0.93%)

Fundamental Rating

5

IEP gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 71 industry peers in the Real Estate Management & Development industry. IEP is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. IEP is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year IEP was profitable.
IEP had a positive operating cash flow in the past year.
IEP had positive earnings in 4 of the past 5 years.
Each year in the past 5 years IEP had a positive operating cash flow.
IEP.BR Yearly Net Income VS EBIT VS OCF VS FCFIEP.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

1.2 Ratios

With a decent Return On Assets value of 1.60%, IEP is doing good in the industry, outperforming 69.01% of the companies in the same industry.
With a decent Return On Equity value of 2.67%, IEP is doing good in the industry, outperforming 60.56% of the companies in the same industry.
The Return On Invested Capital of IEP (3.55%) is better than 78.87% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for IEP is in line with the industry average of 3.60%.
The 3 year average ROIC (3.49%) for IEP is below the current ROIC(3.55%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.6%
ROE 2.67%
ROIC 3.55%
ROA(3y)0.23%
ROA(5y)2.23%
ROE(3y)0.32%
ROE(5y)3.7%
ROIC(3y)3.49%
ROIC(5y)3.8%
IEP.BR Yearly ROA, ROE, ROICIEP.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1.3 Margins

IEP's Profit Margin of 20.96% is fine compared to the rest of the industry. IEP outperforms 74.65% of its industry peers.
IEP's Profit Margin has declined in the last couple of years.
IEP has a better Operating Margin (58.11%) than 81.69% of its industry peers.
In the last couple of years the Operating Margin of IEP has remained more or less at the same level.
Industry RankSector Rank
OM 58.11%
PM (TTM) 20.96%
GM N/A
OM growth 3Y-0.06%
OM growth 5Y1.37%
PM growth 3Y-35.91%
PM growth 5Y-3.66%
GM growth 3YN/A
GM growth 5YN/A
IEP.BR Yearly Profit, Operating, Gross MarginsIEP.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IEP is destroying value.
IEP has about the same amout of shares outstanding than it did 1 year ago.
IEP has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, IEP has an improved debt to assets ratio.
IEP.BR Yearly Shares OutstandingIEP.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
IEP.BR Yearly Total Debt VS Total AssetsIEP.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

An Altman-Z score of 1.97 indicates that IEP is not a great score, but indicates only limited risk for bankruptcy at the moment.
IEP has a Altman-Z score of 1.97. This is amongst the best in the industry. IEP outperforms 87.32% of its industry peers.
IEP has a debt to FCF ratio of 3.87. This is a good value and a sign of high solvency as IEP would need 3.87 years to pay back of all of its debts.
IEP's Debt to FCF ratio of 3.87 is amongst the best of the industry. IEP outperforms 92.96% of its industry peers.
A Debt/Equity ratio of 0.21 indicates that IEP is not too dependend on debt financing.
The Debt to Equity ratio of IEP (0.21) is better than 85.92% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 3.87
Altman-Z 1.97
ROIC/WACC0.49
WACC7.19%
IEP.BR Yearly LT Debt VS Equity VS FCFIEP.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

IEP has a Current Ratio of 10.44. This indicates that IEP is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 10.44, IEP belongs to the best of the industry, outperforming 95.77% of the companies in the same industry.
IEP has a Quick Ratio of 10.44. This indicates that IEP is financially healthy and has no problem in meeting its short term obligations.
IEP's Quick ratio of 10.44 is amongst the best of the industry. IEP outperforms 95.77% of its industry peers.
Industry RankSector Rank
Current Ratio 10.44
Quick Ratio 10.44
IEP.BR Yearly Current Assets VS Current LiabilitesIEP.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

0

3. Growth

3.1 Past

The earnings per share for IEP have decreased by -5.80% in the last year.
The earnings per share for IEP have been decreasing by -14.45% on average. This is quite bad
IEP shows a decrease in Revenue. In the last year, the revenue decreased by -4.15%.
IEP shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -13.18% yearly.
EPS 1Y (TTM)-5.8%
EPS 3Y-50.98%
EPS 5Y-14.45%
EPS Q2Q%-48.45%
Revenue 1Y (TTM)-4.15%
Revenue growth 3Y-23.51%
Revenue growth 5Y-13.18%
Sales Q2Q%-1.25%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IEP.BR Yearly Revenue VS EstimatesIEP.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 33.13, which means the current valuation is very expensive for IEP.
Based on the Price/Earnings ratio, IEP is valued a bit cheaper than 60.56% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.34, IEP is valued a bit more expensive.
Industry RankSector Rank
PE 33.13
Fwd PE N/A
IEP.BR Price Earnings VS Forward Price EarningsIEP.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of IEP indicates a somewhat cheap valuation: IEP is cheaper than 64.79% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 15.78
EV/EBITDA N/A
IEP.BR Per share dataIEP.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

The decent profitability rating of IEP may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

IEP has a Yearly Dividend Yield of 66.04%, which is a nice return.
Compared to an average industry Dividend Yield of 8.01, IEP pays a better dividend. On top of this IEP pays more dividend than 100.00% of the companies listed in the same industry.
IEP's Dividend Yield is rather good when compared to the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 66.04%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
IEP.BR Yearly Dividends per shareIEP.BR Yearly Dividends per shareYearly Dividends per share 2021 2022 1 2 3 4 5

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
IEP.BR Yearly Income VS Free CF VS DividendIEP.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

IEP INVEST

EBR:IEP (6/19/2025, 7:00:00 PM)

5.3

-0.05 (-0.93%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap48.60M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 66.04%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 33.13
Fwd PE N/A
P/S 8
P/FCF 15.78
P/OCF 11.97
P/B 1.02
P/tB 1.02
EV/EBITDA N/A
EPS(TTM)0.16
EY3.02%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.34
FCFY6.34%
OCF(TTM)0.44
OCFY8.36%
SpS0.66
BVpS5.21
TBVpS5.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.6%
ROE 2.67%
ROCE 4.63%
ROIC 3.55%
ROICexc 5.78%
ROICexgc 5.78%
OM 58.11%
PM (TTM) 20.96%
GM N/A
FCFM 50.67%
ROA(3y)0.23%
ROA(5y)2.23%
ROE(3y)0.32%
ROE(5y)3.7%
ROIC(3y)3.49%
ROIC(5y)3.8%
ROICexc(3y)5.67%
ROICexc(5y)6.06%
ROICexgc(3y)5.67%
ROICexgc(5y)6.06%
ROCE(3y)4.55%
ROCE(5y)4.95%
ROICexcg growth 3Y-13.01%
ROICexcg growth 5Y13.34%
ROICexc growth 3Y-13.01%
ROICexc growth 5Y13.34%
OM growth 3Y-0.06%
OM growth 5Y1.37%
PM growth 3Y-35.91%
PM growth 5Y-3.66%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 3.87
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 16.14%
Interest Coverage 4.25
Cash Conversion N/A
Profit Quality 241.76%
Current Ratio 10.44
Quick Ratio 10.44
Altman-Z 1.97
F-Score6
WACC7.19%
ROIC/WACC0.49
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)10.53%
Cap/Sales(5y)13.64%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.8%
EPS 3Y-50.98%
EPS 5Y-14.45%
EPS Q2Q%-48.45%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.15%
Revenue growth 3Y-23.51%
Revenue growth 5Y-13.18%
Sales Q2Q%-1.25%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1.62%
EBIT growth 3Y-23.56%
EBIT growth 5Y-11.98%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y27.91%
FCF growth 3Y8.3%
FCF growth 5YN/A
OCF growth 1Y56.55%
OCF growth 3Y9.92%
OCF growth 5Y-8.63%